CVS beat expectations for third-quarter earnings and raised its guidance. The healthcare group also reported that it would pay $5 billion to settle a wave of cases over its alleged involvement in the opioid crisis. CVS (ticker: CVS) stock gained 5% in premarket trading Wednesday. The company beat expectations and announced it would raise its guidance on its third quarter of fiscal year ending on October 31, 2015. CV Health also announced that it will pay more than $6 billion in penalties for its role in the Opioinics crisis, including $1 billion in fines and jail time for sales of prescription painkillers, among other things, to the tune of $2 billion in the past year. CVS shares rose 5% Wednesday. . . .
Read more at www.barrons.com
